Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

COVID-19 symptoms in the feet

In a review paper recently uploaded to the Journal of Clinical Medicine by Jimenez-Cebrian et al. (May 19th, 2021), the clinical manifestations of COVID-19 in feet, in particular, are reviewed, finding that vascular, dermatological, and neurological symptoms have been widely reported.

6 Jun 2021

High baseline levels of inflammatory cytokines linked to thrombotic events in patients with COVID-19

In a recent open-access paper published in the Journal of Clinical Medicine, researchers from Iran and Germany show that high baseline levels of inflammatory cytokines measured during admission put patients with coronavirus disease (COVID-19) at increased risk of developing coagulopathy, thrombotic events – and even death.

6 Jun 2021

Standardizable assay detects T cell responses to SARS-CoV-2 infection

Researchers in the UK have developed a high-throughput standardizable assay that accurately detects T cell responses to infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

6 Jun 2021

New data from CDC on effectiveness of Pfizer and Moderna COVID-19 vaccines

Researchers in the United States have conducted a study demonstrating the real-world effectiveness of the Pfizer-BioNTech and Moderna coronavirus disease 2019 (COVID-19) vaccines at preventing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

6 Jun 2021

Metformin potently inhibits SARS-CoV-2-induced cytokine release in monocytes

An interesting new bioRxiv* preprint reports the suppression of monocyte glycolysis and cytokine production when exposed to the virus, following pretreatment with the commonly used drug, metformin.

6 Jun 2021

SARS-CoV-2 genome analysis reveals new 'Mexican variant'

A research group of the Department of Pharmacy and Biotechnology of the University of Bologna analyzed more than one million SARS-CoV-2 genome sequences.

5 Jun 2021

Cancer patients on remote monitoring program less likely to require hospitalization for COVID-19

A study by researchers at Mayo Clinic Cancer Center has found that cancer patients diagnosed with COVID-19 who received care at home via remote patient monitoring were significantly less likely to require hospitalization for their illness, compared to cancer patients with COVID-19 who did not participate in the program.

5 Jun 2021

MSU research reveals how the skin's immune cells organize themselves to ward off intruders

It can be easy to forget that the human skin is an organ. It's also the largest one and it's exposed, charged with keeping our inner biology safe from the perils of the outside world.

5 Jun 2021

New study investigates how green tea could lead to a drug for tackling Covid-19

As India continues to be ravaged by the pandemic, a Swansea University academic is investigating how green tea could give rise to a drug capable of tackling Covid-19.

5 Jun 2021

Gene offers some level of protection from severe Covid

The first evidence of a genetic link explaining why some people who catch Covid-19 don't become sick has been discovered.

5 Jun 2021

Study elucidates the use of anticoagulants to treat bleeding in patients with gastrointestinal cancers

A study by Mayo Clinic researchers provides some clarity in the use of direct oral anticoagulants (DOAC), such as apixaban and rivaroxaban, to treat acute venous thromboembolism (VTE) in patients with gastrointestinal cancers.

5 Jun 2021

Mason researchers examine the potential anti-coronavirus activities of an over-the-counter drink

Could an over-the-counter health "shot" help fight COVID-19? George Mason University researchers think it just might.

5 Jun 2021

Study finds no genetic evidence to prove vitamin D protects against coronavirus

While previous research early in the pandemic suggested that the vitamin D cuts the risk of contracting COVID-19, a new study from McGill University finds there is no genetic evidence that the vitamin works as a protective measure against the coronavirus.

5 Jun 2021

First human case of H10N3 influenza reported in Jiangsu, China

As the coronavirus disease (COVID-19) pandemic continues to spread and wreak havoc globally, another health threat emerged in China. The country has reported its first confirmed case of the rare H10N3 bird flu in a patient admitted to the hospital in April 2021 in Zhenjiang, China.

4 Jun 2021

Maternal SARS-CoV-2 infection imprints immune response in the newborn

A new bioRxiv* preprint reports the immunological footprint in the newborn left by maternal infection with SARS-CoV-2 during pregnancy.

4 Jun 2021

Risk of SARS-CoV-2 spread to bats

A recent bioRxiv* preprint offers a powerful risk assessment approach to estimate the risk of bat exposure to SARS-CoV-2 from humans during their interactions in the wild.

4 Jun 2021

SARS-CoV-2 evades neutralizing antibodies and rapidly spreads by cell fusion, finds study

In a new study by researchers in the UK, Germany and South Africa, this process is visualized using time-lapse microscopy of a human cell lung line, demonstrating that SARS-CoV-2 can induce cell-to-cell fusion within 6 hours post-infection. Further, the application of neutralizing monoclonal antibodies or convalescent plasma was unable to prevent the spread of the virus by this mechanism, suggesting that removing SARS-CoV-2 from cells permissive of cell membrane fusion could be more difficult than other types of cell.

4 Jun 2021

In Missouri and other states, flawed data makes it hard to track vaccine equity

Throughout the covid-19 vaccination effort, public health officials and politicians have insisted that providing shots equitably across racial and ethnic groups is a top priority.

4 Jun 2021

Analysis: Mounting pressure on China about Covid ‘lab leak’ could backfire

President Joe Biden has ordered U.S. intelligence agencies to determine whether the Covid virus, or a near ancestor, emerged from a cave, a live-animal market, a farm — or a secretive Chinese laboratory.

4 Jun 2021

Post-COVID-19 assessment shows long-lasting consequences for many non-hospitalized individuals

Complications following COVID-19 infection require quick identification and management to help plan policy and health system responses. Researchers in the UK recently described the 12-month experience of the first dedicated post-COVID clinical service in the UK to include both hospitalized and non-hospitalized COVID-19 patients. This study has been released on the medRxiv* the preprint server.

4 Jun 2021